Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Organized colorectal cancer screening programmes: how to optimize efficiency in the general population

Calazel-Benque, Annea; Viguier, Jérômeb; Roussel, Clairec; Pivot, Xavierd,e; Eisinger, Françoisf,g; Blay, Jean-Yvesh,i; Coscas, Yvanj; Morère, Jean-Françoisk,l

European Journal of Cancer Prevention: January 2011 - Volume 20 - Issue - p S20–S25
doi: 10.1097/01.cej.0000391566.41383.61
Supplement Articles
Buy

In France, free faecal occult blood testing is offered to individuals aged between 50 and 74 years every 2 years as a method of screening for colorectal cancer (CRC). To assess how a proposed organized programme of CRC screening would be perceived among a representative sample of individuals living in France, aged between 40 and 75 years, and by a representative sample of general practitioners, two nationwide observational telephone surveys were carried out in 2005 (EDIFICE 1; 1601 individuals) and 2008 (EDIFICE 2; 1801 individuals). In 2008, 38% of individuals aged between 50 and 74 years reported undergoing screening for CRC; this corresponded to a statistically significant 13% increase in CRC screening rate compared with 2005 (P=0.01). When asked whether it was possible to screen for CRC, 94% of individuals who had undergone screening (N=350) responded positively compared with 87% of individuals who had not been screened. The main reason for individuals not to undergo screening was a lack of awareness (35% of men and 37% of women, P=not significant); the second reason was lack of advice and referral from their general practitioner (21% of women versus 15% of men, P=0.03). The French population is aware of the potential benefit of CRC screening; however, many do not undergo regular screening. It is therefore important to identify the hurdles associated with CRC screening.

aCapio Clinique du Parc, Toulouse

bDepartment of Cancer Screening, University Hospital Centre of Tours

cRoche S.A., Neuilly-sur-Seine

dUniversity Hospital Jean Minjoz

eINSERM U645, Besançon

fPaoli-Calmettes Institute

gINSERM UMR912, Marseille

hLéon Bérard Cancer Center

iINSERM U590, Centre Léon Bérard and Conticanet, Lyon

jPorte de St Cloud Clinic, Boulogne-Billancourt

kAvicenne University Hospital, Bobigny

lUniversity Paris XII, Paris, France

Correspondence to Anne Calazel-Benque, Capio Clinique Du Parc, 105, rue Achille Viadieu, 31400 Toulouse, France Tel: +33 5 61 36 69 98; fax: +33 5 61 36 69 08; e-mail: acalazel@capio.fr

© 2011 Lippincott Williams & Wilkins, Inc.